US5912347A
(en)
*
|
1996-09-30 |
1999-06-15 |
Mallinckrodt Inc. |
Process for preparing a morphinan derivative
|
WO2000066588A1
(en)
*
|
1999-05-05 |
2000-11-09 |
The Government Of The United States Of America, Represented By The Secretary, Departmentof Health A Nd Human Services |
Direct c-14 oxidation of opioids
|
US6177567B1
(en)
|
1999-10-15 |
2001-01-23 |
Boehringer Ingelheim Chemicals, Inc. |
Method for preparing oxycodone
|
HUP0401600A3
(en)
*
|
2001-08-23 |
2008-05-28 |
Organon Nv |
Process for the preparation of 14-hydroxymorphine derivatives
|
JP3961796B2
(ja)
*
|
2001-08-27 |
2007-08-22 |
ソニー株式会社 |
情報提供システム、情報処理装置および方法、情報提供装置および方法、記録媒体、並びにプログラム
|
DE10161963A1
(de)
*
|
2001-12-17 |
2003-07-03 |
Johannes Schuetz |
6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20040058946A1
(en)
*
|
2002-07-05 |
2004-03-25 |
Buchwald Stephen L. |
Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
|
RU2236412C2
(ru)
*
|
2002-07-18 |
2004-09-20 |
Власов Михаил Иванович |
Способ получения производных морфинона, способ получения производных 14-гидроксиморфинона, и способ получения производных оксиморфона
|
RU2215742C1
(ru)
*
|
2002-11-05 |
2003-11-10 |
Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" |
Способ получения сложных эфиров n-замещенных 14-гидроксиморфинанов
|
RU2215741C1
(ru)
*
|
2002-11-05 |
2003-11-10 |
Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" |
Сложные эфиры n-замещенных 14-гидроксиморфинанов и способ их получения
|
CA2504262C
(en)
*
|
2002-11-08 |
2012-01-10 |
Mallinckrodt, Inc. |
Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
|
PT2218448E
(pt)
*
|
2002-12-13 |
2016-01-26 |
Durect Corp |
Sistema oral de entrega de fármaco que compreende materiais transportadores líquidos de alta viscosidade
|
US6864370B1
(en)
|
2003-06-05 |
2005-03-08 |
Zhaiwei Lin |
Process for manufacturing oxycodone
|
US6790959B1
(en)
|
2003-06-05 |
2004-09-14 |
Halsey Drug Company, Inc. |
Process for manufacturing thebaine
|
ES2627995T3
(es)
|
2003-09-22 |
2017-08-01 |
Glaxosmithkline Australia Pty Ltd |
Procedimiento para la síntesis de compuestos de morfinano y productos intermedios de los mismos
|
US7875718B2
(en)
*
|
2003-09-22 |
2011-01-25 |
Johnson Matthey Public Limited Company |
Process for the synthesis of morphinane compounds and intermediates thereof
|
RS51317B
(sr)
|
2004-02-06 |
2010-12-31 |
Euro-Celtique S.A. |
Postupci pravljenja 3-0 zaštićenih morfinona i 3-0 zaštićenih morfinon dienol karboksilata
|
TW201509943A
(zh)
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
SK286047B6
(sk)
*
|
2004-04-13 |
2008-01-07 |
Zentiva, A. S. |
Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
|
US6946556B1
(en)
*
|
2004-05-21 |
2005-09-20 |
Acura Pharmaceuticals, Inc. |
Preparation of opioid analgesics by a one-pot process
|
WO2005123743A1
(en)
*
|
2004-06-08 |
2005-12-29 |
Mallinckrodt Inc. |
Extraction of alkaloids from opium
|
CA2569958C
(en)
|
2004-06-12 |
2016-03-22 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
RS52198B
(en)
|
2004-09-17 |
2012-10-31 |
Durect Corporation |
LOCAL ANESTHETIC SOLUTION CONTAINING SAIB SUSTAINABLE ACTION
|
GB0421149D0
(en)
*
|
2004-09-23 |
2004-10-27 |
Johnson Matthey Plc |
Preparation of oxycodone
|
GB0421687D0
(en)
*
|
2004-09-30 |
2004-11-03 |
Johnson Matthey Plc |
Preparation of opiate analgesics
|
WO2006084389A1
(de)
*
|
2005-02-11 |
2006-08-17 |
Cilag Ltd. |
Verfahren zur reinigung von noroxymorphon-verbindungen
|
CN101133062B
(zh)
*
|
2005-03-04 |
2014-08-06 |
欧洲凯尔特公司 |
减少阿片样物质组合物中α,β-不饱和酮的方法
|
NZ563133A
(en)
*
|
2005-04-06 |
2010-07-30 |
Toray Industries |
Crystals of morphinan derivative and process for producing the same
|
US8071768B2
(en)
*
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
WO2006138020A2
(en)
*
|
2005-06-16 |
2006-12-28 |
Mallinckrodt Inc. |
A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US20070117826A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Forest Laboratories, Inc. |
Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
|
JP5695296B2
(ja)
|
2006-03-02 |
2015-04-01 |
マリンクロッド エルエルシー |
低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8115002B2
(en)
*
|
2006-09-20 |
2012-02-14 |
Mallinckrodt Llc |
Preparation of substituted morphinan-6-ones and salts and intermediates thereof
|
AU2012216358B2
(en)
*
|
2006-10-17 |
2014-11-20 |
Penick Corporation |
Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
|
CA2674915C
(en)
|
2006-10-17 |
2015-06-30 |
Penick Corporation |
Process for preparing oxymorphone
|
DK2073636T3
(da)
|
2006-10-17 |
2012-11-19 |
Penick Corp |
Fremgangsmåde til fremstilling af oxymorphon
|
US20080125592A1
(en)
*
|
2006-10-17 |
2008-05-29 |
Penick Corporation |
Process for preparing oxymorphone, naltrexone, and buprenorphine
|
EP2117521B1
(en)
|
2006-11-03 |
2012-06-27 |
Durect Corporation |
Transdermal delivery systems comprising bupivacaine
|
AU2007329453B2
(en)
*
|
2006-12-04 |
2013-04-04 |
Noramco, Llc |
Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
|
CN104761561A
(zh)
*
|
2006-12-04 |
2015-07-08 |
诺拉姆科有限公司 |
减少羟考酮碱中杂质的方法
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
US9040726B2
(en)
|
2007-03-06 |
2015-05-26 |
Mallinckrodt Llc |
Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
|
WO2008109156A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Mallinckrodt Inc. |
Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
|
WO2008118654A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Mallinckrodt Inc. |
Improved preparation of oxymorphone from oripavine
|
WO2008130553A1
(en)
*
|
2007-04-16 |
2008-10-30 |
Mallinckrodt Inc. |
Novel opiate reduction utilizing catalytic hydrogen transfer reaction
|
US20090018154A1
(en)
*
|
2007-05-17 |
2009-01-15 |
Endo Pharmaceuticals, Inc., A Corporation Of Delaware |
Opioid and methods of making and using the same
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
ES2569655T3
(es)
*
|
2007-12-17 |
2016-05-12 |
Mallinckrodt Llc |
Procedimientos para la producción de compuestos de (+)-'nal' morfinano
|
NZ586187A
(en)
|
2007-12-17 |
2013-07-26 |
Mallinckrodt Llc |
Processes for the synthesis of sinomenine derivatives and their intermediate
|
US7999105B2
(en)
*
|
2008-02-29 |
2011-08-16 |
Mallinckrodt Inc. |
Process for the preparation of 3-hydroxymorphinan derivatives
|
KR101598137B1
(ko)
*
|
2008-04-24 |
2016-02-29 |
얀센 파마슈티카 엔.브이. |
날메펜 프로드럭
|
CA2726220C
(en)
*
|
2008-05-27 |
2017-03-28 |
Mallinckrodt Inc. |
Processes and compounds for the preparation of normorphinans
|
WO2010028004A2
(en)
|
2008-09-03 |
2010-03-11 |
Mallinckrodt Inc. |
Substituted berbines and processes for their synthesis
|
PL2344506T3
(pl)
*
|
2008-09-30 |
2016-08-31 |
SpecGx LLC |
Sposoby alkilowania grup aminy drugorzędowej pochodnych morfinanowych
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
UA102916C2
(uk)
|
2009-07-02 |
2013-08-27 |
Кемфарм, Інк. |
Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011154826A1
(en)
|
2010-06-11 |
2011-12-15 |
Rhodes Technologies |
Process for n-dealkylation of tertiary amines
|
JP5736040B2
(ja)
|
2010-06-11 |
2015-06-17 |
ローズ テクノロジーズ |
N−アリル化合物の調製のための遷移金属触媒プロセスおよびその使用
|
EP2588481B1
(en)
|
2010-07-02 |
2017-11-15 |
Johnson Matthey Public Limited Company |
Process for the synthesis and purification of oxycodone
|
RU2448709C1
(ru)
*
|
2011-02-01 |
2012-04-27 |
Учреждение Российской академии наук Институт проблем химико-энергетических технологий Сибирского отделения РАН (ИПХЭТ СО РАН) |
Способ получения налтрексона
|
TWI560170B
(en)
*
|
2011-12-06 |
2016-12-01 |
Lundbeck & Co As H |
Process for recovery of nalmefene hydrochloride
|
US9315514B2
(en)
|
2012-08-27 |
2016-04-19 |
Rhodes Technologies |
1,3-dioxanomorphides and 1,3-dioxanocodides
|
US8980906B2
(en)
|
2012-12-14 |
2015-03-17 |
Purdue Pharma L.P. |
Pyridonemorphinan analogs and biological activity on opioid receptors
|
TW201434837A
(zh)
|
2012-12-14 |
2014-09-16 |
Purdue Pharma Lp |
螺環嗎啡喃及其用途
|
EP2931725B1
(en)
|
2012-12-14 |
2017-02-15 |
Purdue Pharma LP |
Nitrogen containing morphinan derivatives and the use thereof
|
TW201441198A
(zh)
|
2012-12-28 |
2014-11-01 |
Purdue Pharma Lp |
7,8-環嗎啡喃類似物
|
EP2941431B1
(en)
|
2012-12-28 |
2017-10-25 |
Purdue Pharma L.P. |
Substituted morphinans and the use thereof
|
WO2014102591A1
(en)
|
2012-12-31 |
2014-07-03 |
Rhodes Technologies |
PROCESS FOR PREPARING 7β-SUBSTITUTED 6α,14α -ETHENOMORPHINANS AND 7β-SUBSTITUTED 6α,14α-ETHANOMORPHINANS
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
EP2829541A1
(en)
*
|
2013-07-26 |
2015-01-28 |
Siegfried AG |
Novel synthesis of noroxymorphone from morphine
|
CA2919602C
(en)
|
2013-08-02 |
2018-03-13 |
Johnson Matthey Public Limited Company |
Process for the preparation of oxymorphone
|
EP3087078B1
(en)
|
2013-12-26 |
2019-05-15 |
Purdue Pharma LP |
7-beta-alkyl analogs of orvinols
|
US9994571B2
(en)
|
2013-12-26 |
2018-06-12 |
Purdue Pharma L.P. |
10-substituted morphinan hydantoins
|
US9340542B2
(en)
|
2013-12-26 |
2016-05-17 |
Purdue Pharma L.P. |
Propellane-based compounds and the use thereof
|
WO2015097545A1
(en)
|
2013-12-26 |
2015-07-02 |
Purdue Pharma L.P. |
Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
|
US9902726B2
(en)
|
2013-12-30 |
2018-02-27 |
Purdue Pharma L.P. |
Pyridone-sulfone morphinan analogs as opioid receptor ligands
|
KR20190049944A
(ko)
|
2014-11-25 |
2019-05-09 |
켐팜 인코포레이티드 |
옥시코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트
|
EP3252055B1
(en)
|
2016-05-31 |
2018-09-19 |
Alcaliber Investigacion Desarrollo e Innovacion SLU |
Process for obtaining 3,14-diacetyloxymorphone from oripavine
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
KR102413459B1
(ko)
|
2016-07-06 |
2022-06-24 |
듀렉트 코퍼레이션 |
약물 조성물, 장벽 층 및 약물 층을 갖는 경구 투여 형태
|
MX379709B
(es)
|
2016-12-23 |
2025-03-11 |
Minoryx Therapeutics S L |
Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil] etoxi]fenil]metil]-2,4-tiazolidindiona y sus sales.
|
SK592017A3
(sk)
|
2017-07-04 |
2019-01-08 |
Saneca Pharmaceuticals A. S. |
Spôsob prípravy morfínanových zlúčenín
|
CA3091826A1
(en)
|
2018-02-23 |
2019-08-29 |
Rhodes Technologies |
Novel opioid compounds and uses thereof
|
CN110054656B
(zh)
*
|
2019-05-28 |
2021-02-02 |
宜昌人福药业有限责任公司 |
一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
|
US11613547B2
(en)
|
2019-07-08 |
2023-03-28 |
University Of Health Sciences & Pharmacy In St. Louis |
G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
|
BR112022013784A2
(pt)
|
2020-01-13 |
2022-10-11 |
Durect Corp |
Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
|
CN114621239A
(zh)
*
|
2020-12-10 |
2022-06-14 |
鲁南制药集团股份有限公司 |
一种纳曲酮的制备方法
|
EP4267583A4
(en)
*
|
2020-12-28 |
2024-10-30 |
Navin Saxena Research & Technology Pvt. Ltd. |
NEW PROCESS FOR THE PRODUCTION OF NOROXYMORPHONE FROM MORPHINE
|